Richard C. Mohs

基本信息

浏览量：152

职业迁徙

个人简介

Dr. Mohs is currently an independent consultant specializing in development of drugs for CNS indications. He has experience in all phases of clinical development.

研究兴趣

论文共 439 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

The HOPE4MCI study: A randomized double-blind assessment of AGB101 for the treatment of MCI due to AD

Richard Mohs, Arnold Bakker,Sharon Rosenzweig-Lipson,Michael Rosenblum, Russell L. Barton,Marilyn S. Albert,Sharon Cohen,Scott Zeger,Michela Gallagher

ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONSno. 1 (2024): e12446-e12446

引用0浏览0WOS引用

The Bio-Hermes Study: Biomarker database developed to investigate blood-based and digital biomarkers in community-based, diverse populations clinically screened for Alzheimer's disease

Richard C Mohs, Douglas Beauregard,John Dwyer, Jennifer Gaudioso,Jason Bork, Tamiko MaGee-Rodgers, Mickeal N Key,Diana R Kerwin, Lynn Hughes, Cyndy B Cordell, Bio‐Hermes Collaborative Group

Alzheimer's & dementia : the journal of the Alzheimer's Associationno. 4 (2024): 2752-2765

引用0浏览0WOS引用

CERAD (Consortium to Establish a Registry for Alzheimer's Disease) Neuropsychology Assessment Battery: 35 Years and Counting

Gerda G Fillenbaum,Richard Mohs

Journal of Alzheimer's disease : JADno. 1 (2023): 1-27

引用6浏览0WOS引用

Bio‐Hermes: A Validation Study to Assess a Meaningful Relationship Between Blood and Digital Biomarkers with Aβ PET Scans for Alzheimer’s Disease